Trial intelligence / Profile preview

Effects of mannitol and hypertonic saline on hemodynamics, acid-base balance and blood coagulation in goal-directed fluid therapy in subarachnoid haemorrhage patients

2009-015784-13Phase 4Terminated

Sponsor
Teemu Luostarinen
Start
Feb 2011
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4 trial of Bronchitol and sodium chloride in subarachnoid hemorrhage (SAH), sponsored by Teemu Luostarinen. Primary endpoints: Hemodynamic effects, Acid-base balance and 1 more. Started Feb 2011; status: terminated.

02

Drugs

Bronchitolsodium chloride
03

Conditions

subarachnoid hemorrhage (SAH)

Beyond the preview

Go deeper on 2009-015784-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-015784-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call